Latest stories on MCRB
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralgeneral
Seres Therapeutics files $300M mixed securities shelf
The Fly28 · bearishgeneral
Seres Therapeutics EPS of $0.47, revenue of $0.74M beats by $0.56M
Seeking Alpha68 · bullishearnings
Seres Therapeutics, Inc. (MCRB) files 8-K
SEC 8-K50 · neutralgeneral
Seres Therapeutics reports positive SER-155 trial results
TipRanks73 · bullishproduct/pr
Seres Therapeutics, Inc. (MCRB) files 8-K
SEC 8-K50 · neutralgeneral
Seres Therapeutics Reshapes Finances with Lease Restructuring
TipRanks56 · neutralgeneral